Annual Non Current Assets
$70.99 M
-$191.19 M-72.92%
31 December 2023
Summary:
Sangamo Therapeutics annual long term assets is currently $70.99 million, with the most recent change of -$191.19 million (-72.92%) on 31 December 2023. During the last 3 years, it has fallen by -$207.89 million (-74.54%). SGMO annual non current assets is now -78.03% below its all-time high of $323.15 million, reached on 31 December 2021.SGMO Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$53.13 M
+$193.00 K+0.36%
30 September 2024
Summary:
Sangamo Therapeutics quarterly long term assets is currently $53.13 million, with the most recent change of +$193.00 thousand (+0.36%) on 30 September 2024. Over the past year, it has dropped by -$18.99 million (-26.33%). SGMO quarterly non current assets is now -83.65% below its all-time high of $325.00 million, reached on 30 September 2021.SGMO Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SGMO Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -72.9% | -26.3% |
| 3 y3 years | -74.5% | -83.7% |
| 5 y5 years | -60.5% | -79.3% |
SGMO Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -78.0% | at low | -83.7% | +0.4% |
| 5 y | 5 years | -78.0% | at low | -83.7% | +0.4% |
| alltime | all time | -78.0% | >+9999.0% | -83.7% | >+9999.0% |
Sangamo Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $53.13 M(+0.4%) |
| June 2024 | - | $52.94 M(-12.2%) |
| Mar 2024 | - | $60.33 M(-15.0%) |
| Dec 2023 | $94.33 M(-68.6%) | $70.99 M(-1.6%) |
| Sept 2023 | - | $72.12 M(-56.4%) |
| June 2023 | - | $165.47 M(-22.5%) |
| Mar 2023 | - | $213.48 M(-18.6%) |
| Dec 2022 | $300.33 M(-24.7%) | $262.18 M(+1.9%) |
| Sept 2022 | - | $257.29 M(-6.1%) |
| June 2022 | - | $274.01 M(-12.8%) |
| Mar 2022 | - | $314.25 M(-2.8%) |
| Dec 2021 | $398.77 M(-39.6%) | $323.15 M(-0.6%) |
| Sept 2021 | - | $325.00 M(+15.5%) |
| June 2021 | - | $281.30 M(+4.1%) |
| Mar 2021 | - | $270.15 M(-3.1%) |
| Dec 2020 | $659.67 M(+62.7%) | $278.88 M(+5.9%) |
| Sept 2020 | - | $263.42 M(+22.4%) |
| June 2020 | - | $215.26 M(+0.9%) |
| Mar 2020 | - | $213.33 M(-8.1%) |
| Dec 2019 | $405.47 M(-1.2%) | $232.04 M(-9.4%) |
| Sept 2019 | - | $256.05 M(+21.0%) |
| June 2019 | - | $211.67 M(+17.5%) |
| Mar 2019 | - | $180.10 M(+0.1%) |
| Dec 2018 | $410.52 M(+65.3%) | $179.87 M(+30.0%) |
| Sept 2018 | - | $138.40 M(+78.2%) |
| June 2018 | - | $77.68 M(+73.0%) |
| Mar 2018 | - | $44.89 M(+17.1%) |
| Dec 2017 | $248.40 M(+66.1%) | $38.34 M(+39.7%) |
| Sept 2017 | - | $27.45 M(+0.5%) |
| June 2017 | - | $27.32 M(+109.5%) |
| Mar 2017 | - | $13.04 M(+56.9%) |
| Dec 2016 | $149.58 M(-29.6%) | $8.31 M(-48.5%) |
| Sept 2016 | - | $16.13 M(+239.2%) |
| June 2016 | - | $4.76 M(-19.5%) |
| Mar 2016 | - | $5.91 M(+27.0%) |
| Dec 2015 | $212.58 M(+11.4%) | $4.65 M(-3.7%) |
| Sept 2015 | - | $4.83 M(-46.0%) |
| June 2015 | - | $8.94 M(-74.1%) |
| Mar 2015 | - | $34.56 M(-34.0%) |
| Dec 2014 | $190.88 M(+96.2%) | $52.33 M(-29.4%) |
| Sept 2014 | - | $74.18 M(+55.0%) |
| June 2014 | - | $47.86 M(+35.6%) |
| Mar 2014 | - | $35.29 M(-19.0%) |
| Dec 2013 | $97.27 M(+42.3%) | $43.56 M(+206.3%) |
| Sept 2013 | - | $14.22 M(-30.5%) |
| June 2013 | - | $20.48 M(+43.2%) |
| Mar 2013 | - | $14.30 M(+0.9%) |
| Dec 2012 | $68.36 M | $14.17 M(-27.1%) |
| Sept 2012 | - | $19.42 M(-14.3%) |
| June 2012 | - | $22.65 M(+163.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | $8.60 M(+423.1%) |
| Dec 2011 | $85.69 M(+39.8%) | $1.64 M(+2.4%) |
| Sept 2011 | - | $1.61 M(+0.9%) |
| June 2011 | - | $1.59 M(-65.7%) |
| Mar 2011 | - | $4.64 M(+175.5%) |
| Dec 2010 | $61.31 M(-28.5%) | $1.69 M(-6.3%) |
| Sept 2010 | - | $1.80 M(-3.8%) |
| June 2010 | - | $1.87 M(-1.1%) |
| Mar 2010 | - | $1.89 M(+13.5%) |
| Dec 2009 | $85.77 M(+30.3%) | $1.67 M(-1.9%) |
| Sept 2009 | - | $1.70 M(-5.8%) |
| June 2009 | - | $1.80 M(-5.6%) |
| Mar 2009 | - | $1.91 M(-4.5%) |
| Dec 2008 | $65.85 M(-19.8%) | $2.00 M(-5.6%) |
| Sept 2008 | - | $2.12 M(+2.0%) |
| June 2008 | - | $2.07 M(+2.0%) |
| Mar 2008 | - | $2.03 M(+14.1%) |
| Dec 2007 | $82.12 M(+49.2%) | $1.78 M(+31.7%) |
| Sept 2007 | - | $1.35 M(+14.5%) |
| June 2007 | - | $1.18 M(+47.8%) |
| Mar 2007 | - | $800.00 K(+10.5%) |
| Dec 2006 | $55.06 M(+13.6%) | $724.00 K(+36.1%) |
| Sept 2006 | - | $532.00 K(-6.0%) |
| June 2006 | - | $566.00 K(-17.5%) |
| Mar 2006 | - | $686.00 K(+31.7%) |
| Dec 2005 | $48.46 M(+41.0%) | $521.00 K(+37.8%) |
| Sept 2005 | - | $378.00 K(-8.9%) |
| June 2005 | - | $415.00 K(+39.7%) |
| Mar 2005 | - | $297.00 K(-14.9%) |
| Dec 2004 | $34.38 M(-24.1%) | $349.00 K(-16.7%) |
| Sept 2004 | - | $419.00 K(-26.0%) |
| June 2004 | - | $566.00 K(-26.6%) |
| Mar 2004 | - | $771.00 K(-18.6%) |
| Dec 2003 | $45.28 M(-16.3%) | $947.00 K(-16.9%) |
| Sept 2003 | - | $1.14 M(-15.4%) |
| June 2003 | - | $1.35 M(-29.5%) |
| Mar 2003 | - | $1.91 M(-10.2%) |
| Dec 2002 | $54.10 M(-15.2%) | $2.13 M(-9.7%) |
| Sept 2002 | - | $2.36 M(-88.7%) |
| June 2002 | - | $20.87 M(-0.2%) |
| Mar 2002 | - | $20.91 M(-1.6%) |
| Dec 2001 | $63.77 M(-4.1%) | $21.25 M(-1.2%) |
| Sept 2001 | - | $21.51 M(+618.1%) |
| June 2001 | - | $3.00 M(+9.5%) |
| Mar 2001 | - | $2.73 M(+13.3%) |
| Dec 2000 | $66.51 M(+711.1%) | $2.41 M(-87.4%) |
| Sept 2000 | - | $19.12 M(+41.5%) |
| June 2000 | - | $13.51 M(+1223.2%) |
| Mar 2000 | - | $1.02 M |
| Dec 1999 | $8.20 M | - |
FAQ
- What is Sangamo Therapeutics annual long term assets?
- What is the all time high annual non current assets for Sangamo Therapeutics?
- What is Sangamo Therapeutics annual non current assets year-on-year change?
- What is Sangamo Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Sangamo Therapeutics?
- What is Sangamo Therapeutics quarterly non current assets year-on-year change?
What is Sangamo Therapeutics annual long term assets?
The current annual non current assets of SGMO is $70.99 M
What is the all time high annual non current assets for Sangamo Therapeutics?
Sangamo Therapeutics all-time high annual long term assets is $323.15 M
What is Sangamo Therapeutics annual non current assets year-on-year change?
Over the past year, SGMO annual long term assets has changed by -$191.19 M (-72.92%)
What is Sangamo Therapeutics quarterly long term assets?
The current quarterly non current assets of SGMO is $53.13 M
What is the all time high quarterly non current assets for Sangamo Therapeutics?
Sangamo Therapeutics all-time high quarterly long term assets is $325.00 M
What is Sangamo Therapeutics quarterly non current assets year-on-year change?
Over the past year, SGMO quarterly long term assets has changed by -$18.99 M (-26.33%)